(NASDAQ: KMTS) Kestra Medical Technologies's forecast annual revenue growth rate of 36.96% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.68%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.43%.
Kestra Medical Technologies's revenue in 2026 is $74,259,000.On average, 9 Wall Street analysts forecast KMTS's revenue for 2026 to be $5,412,749,902, with the lowest KMTS revenue forecast at $5,165,466,615, and the highest KMTS revenue forecast at $5,605,885,267. On average, 9 Wall Street analysts forecast KMTS's revenue for 2027 to be $7,951,808,943, with the lowest KMTS revenue forecast at $7,436,586,805, and the highest KMTS revenue forecast at $8,546,969,283.
In 2028, KMTS is forecast to generate $11,295,209,680 in revenue, with the lowest revenue forecast at $10,761,899,335 and the highest revenue forecast at $11,843,107,287.